Biotechnology Industry in Japan: Market Research Reports, Statistics and Analysis

Biosimilar Market Analysis In The United States And Japan

... Be treated as a unique entity diclofenac = monoclonal antibodies shown within the circles: the reference product and each biosimilar has different post-translational modifications (in this case ...

Biotechnology Sector In Japan

The Japanese Biological Therapy Business : Innovation And Technol ...

Japan: Brief Overview, 2013, Focus On Biotechnology

... Proteins into the medium, and its Generally regarded as safe (Gras) status [1,2]. B. Subtilis is also one of the best-characterized model microorganisms, as a result of extensive biochemical, genetic ...

The Japanese Genetic Sector Analysis

... Studied single gene disorders Now more complex genetic disorders and environment Many designs same as epidemiology (e.G., Case-control) Some specialized analysis methods. Population genetics ...

Company Report: Biopharmaceutical In Japan And France For Year 20 ...

... Stem cells, to pharmaceutical and biotechnology companies for the production of therapeutic and prophylactic viral vaccines, virosomes, vlps and recombinant proteins, including monoclonal antibodies ...

Company Report: Biopharmaceutical In Japan And France For Year 20 ...

Company Report: Biological Therapy In Japan For Year 2012

... Drug for lysosomal storage diseases, licensed to glaxosmithkline group, was started. As a result, despite the nhi price reduction effected in april, the sales of core products, growject and epoetin ...

Company Report: Biological Therapy In Japan For Year 2012

... To reduce selling, general and administrative (sg&a) expenses in the cell therapy technology development segment from the level recorded in the same period in the previous fiscal year. As a result ...